By Adam Feuerstein and Damian Garde and Matthew Herper
Mike Reddy for STAT
The decline in biotech has erased billions in value and led even seasoned investors to question whether the industry has further to fall.
Read More
By Damian Garde and Adam Feuerstein
Steven Senn/AP
Samsung Biologics is acquiring Biogen’s ownership in Samsung Bioepis, which manufactures off-patent versions of biologic medicines called biosimilars.
By Ed Silverman
Alex Hogan/STAT
From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.
Sponsor content by STAT Events
The way doctors treat cancer is evolving. On Feb. 2, STAT looks into this by examining how advances in technology are changing the way biomarkers are used. Register here to join the conversation.
By Andrew Joseph
SAJJAD HUSSAIN/AFP via Getty Images
New data show that vaccines still protect against a spinoff of the Omicron variant, a welcome sign about the latest coronavirus iteration.
Friday, January 28, 2022
No comments:
Post a Comment